| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 28,301 | 21,471 |
| Depreciation and amortization | 6,535 | 4,506 |
| Net amortization of premiums and (accretion of discounts) | -285 | -175 |
| Provision for credit losses | 9,850 | 9,899 |
| Proceeds from sales of loans originated to sell | -12,224 | -12,224 |
| Net change in mortgage loans held for sale | 34,436 | 18,344 |
| Net gains on mortgage banking | 22,395 | 13,508 |
| Net gains on sale of loans | 459 | 210 |
| Proceeds from sales of assets held for sale | -2,308 | -982 |
| Loss on bank premises and equipment and assets held for sale | 191 | 111 |
| Earnings on bank-owned life insurance | 1,319 | 863 |
| Gain on bank-owned life insurance death benefit | 0 | 0 |
| Stock-based compensation expense | 61 | 49 |
| Gains on panacea financial holdings investment | 32,322 | 32,028 |
| Gains on other investments | 126 | -255 |
| Deferred income tax expense (benefit) | -7,374 | -5,594 |
| Net change in fair value of loan derivative | 4,102 | 3,334 |
| Net (increase) decrease in other assets | 546 | 2,542 |
| Net increase (decrease) in other liabilities | 2,404 | 2,308 |
| Proceeds from bank-owned life insurance death benefit | - | 0 |
| Net cash and cash equivalents (used in) provided by operating activities | -17,968 | -6,587 |
| Purchases of securities available-for-sale | 18,460 | 18,460 |
| Proceeds from paydowns, maturities and calls of securities available-for-sale | 27,615 | 18,680 |
| Proceeds from paydowns, maturities and calls of securities held-to-maturity | 879 | 585 |
| Net increase in frb and fhlb stock | -3,998 | 39 |
| Net change in loans held for investment | 299,072 | 173,799 |
| Purchases of other investments | - | -164 |
| Proceeds from sales of loans initially originated to be held for investment | 57,093 | 52,902 |
| Proceeds from sale of panacea financial holdings investment | 22,091 | - |
| Proceeds from sale of other investment | 432 | - |
| Net (increase) decrease in other investments | -49 | - |
| Net cash and cash equivalents used in investing activities | -213,469 | -119,889 |
| Net increase in deposits | 155,770 | 162,091 |
| Increase in securities sold under agreements to repurchase | -36 | -452 |
| Repayments of secured borrowings, net | -1,792 | -746 |
| Repayment of short-term fhlb advances | 0 | 0 |
| Cash dividends paid on common stock | 7,409 | 4,945 |
| Repurchase of common stock | 807 | 807 |
| Proceeds from exercised stock options | 15 | 0 |
| Repurchase of restricted stock | 0 | 0 |
| Increase in short-term fhlb advances | 85,000 | - |
| Issuance of panacea financial holdings stock, net of costs | 0 | 0 |
| Net cash and cash equivalents provided by financing activities | 230,813 | 156,045 |
| Net change in cash and cash equivalents | -624 | 29,569 |
| Cash and cash equivalents at beginning of period | 64,505 | - |
| Cash and cash equivalents at end of period | 63,881 | - |
Primis Financial Corp. (FRST)
Primis Financial Corp. (FRST)